BOI:EPA
Boiron USA
19,10 €
arrow_upward
+0,26%(+0,050) 1D
5-ноя., 09:00:22 GMT+1 · EUR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for BOI...
Open
19,10 €
High
19,10 €
Low
19,10 €
Mkt. cap
335,12 млн
Avg. vol.
5,00 миң
Volume
26,00
P/E ratio
12,66
52-wk high
32,25 €
52-wk low
16,90 €
EPS
1,51 €
Shares outstanding
17,55 млн
No. of employees
3 миң
Open
19,10 €
High
19,10 €
Low
19,10 €
Mkt. cap
335,12 млн
Avg. vol.
5,00 миң
Volume
26,00
P/E ratio
12,66
52-wk high
32,25 €
52-wk low
16,90 €
EPS
1,51 €
Shares outstanding
17,55 млн
No. of employees
3 миң
News stories
From web sources and news partners
JHNewsAndGuide.com
·
1 саат мурун
Stocks surge, and the Dow soars 1,500 points as oil prices tumble following the US midterm elections
TradingView
·
1 саат мурун
DJI: Dow Jones Jumps 3% in Stunning Post-Election Turnaround, AI Stocks Miss Out
THP News
·
6 мүнөт мурун
Hilton Moves Its Stock Listing to Nasdaq
Profile
Boiron is a manufacturer of homeopathic products, headquartered in France and with an operating presence in 59 countries worldwide. It is the largest manufacturer of homeopathic products in the world. In 2004, it had a workforce of 2,779 and turnover of € 313 million. It is a member of the CAC Small stock index.
In June 2005, the firm acquired Dolisos Laboratories, then the world's second largest manufacturer of homeopathic preparations.
Products of Boiron include mono- and poly-preparations, which Boiron refer to as "proprietary drugs".
Homeopathy is a pseudoscience with no evidence of effectiveness for stated claims or plausible mechanism of medicinal effect, and several class action lawsuits have been filed on behalf of consumers claiming that Boiron's homeopathic products, including Children's Coldcalm and Oscillococcinum, are useless and Boiron's marketing of these products is deceptive. Wikipedia
About Boiron USA
CEO-
Employees2,62 миң
Founded1932-ж., 7-июн.
Headquarters-
SectorPharmaceutical industry
Industry-
Websiteboiron.fr